BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a leading provider of products and services that improve productivity and results in biopharmaceutical manufacturing and in clinical, analytical and research laboratories, today announced that Charles Wagner has been appointed to succeed Kathleen Allen as the Company’s Chief Financial Officer (CFO). Mr. Wagner will assume the role on August 15, 2007, and Ms. Allen will stay on with Millipore through February 18, 2008 to assist with the transition.
